KRAS and colorectal cancer: To the best of our knowledge, this appears to be the first study examining ERK expression in mismatch repair deficient and mismatch repair proficient colorectal cancer simultaneously with upstream gene alterations such as K-ras and B-raf mutations, which contribute to MAPK activation.